QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CSTL

QT61Castle Biosciences, Inc.
NASDAQ·Healthcare·Medical - Diagnostics & Research·USA
Latest market price
21.12
+0.87+4.30%
OverviewShort InterestFilings
CSTLQT61Castle Biosciences, Inc.·NASDAQ
OverviewShort InterestFilings
21.12+4.30%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06NTRA+2.19%$231.41IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44
Snapshot
Index-P/E-EPS (ttm)-0.44
Insider Own2.48%
Shs Outstand30.33M
Perf Week0.52%
Market Cap614.18MForward P/E-EPS next Y-0.93Insider Trans1.23%Shs Float-Perf Month10.00%
Enterprise Value587.14MPEG0.47EPS next Q-0.38Inst Own-Short Float-Perf Quarter-17.82%
Income-13020648.00P/S1.81EPS this Y-230.20%Inst Trans-Short Ratio-Perf Half Y-45.92%
Sales339.92MP/B1.31EPS next Y35.99%ROA-2.34%Short Interest-Perf YTD-45.71%
Book/sh15.20P/C12.54EPS next 5Y-ROE-2.77%52W High44.28 -52.30%Perf Year13.92%
Cash/sh8.64P/FCF135.94EPS past 3/5Y-ROIC-4.82%52W Low14.59 44.76%Perf 3Y-
Dividend Est.-EV/EBITDA-809.10Sales past 3/5Y35.92% 40.42%Gross Margin77.07%Volatility2.40% 2.85%Perf 5Y-
Dividend TTM-EV/Sales1.73EPS Y/Y TTM-170.97%Oper. Margin-9.79%ATR (14)1.01Perf 10Y-
Dividend Ex-Date-Quick Ratio6.53Sales Y/Y TTM2.41%Profit Margin-3.77%RSI (14)50.63Recom2.00
Dividend Gr. 3/5Y-Current Ratio6.75EPS Q/Q-145.00%SMA201.79%Beta0.83Target Price43.50
Payout0.00%Debt/Eq0.08Sales Q/Q-4.55%SMA50-3.67%Rel Volume1.81Prev Close20.25
Employees784LT Debt/Eq0.08EarningsAug 03SMA200-26.43%Avg Volume398.50KPrice21.12
IPO DateJul 25, 2019Option/ShortYes / YesEPS/Sales Surpr.0.00% 6.33%Net Debt/EBITDA37.26Volume720,100Change4.30%
Analyst Ratings
DateActionAnalystRatingTarget
May-29-26ReiteratedKeyBancOverweight$50 → $35
Apr-20-26ReiteratedCanaccord GenuityBuy$50 → $40
Jan-29-26ReiteratedKeyBancOverweight$36 → $50
Jan-26-26ReiteratedGuggenheimBuy$43 → $47
Jan-12-26ReiteratedLake StreetBuy$52
Jan-05-26ReiteratedGuggenheimBuy$30 → $43
Dec-22-25ReiteratedCanaccord GenuityBuy$42 → $50
Dec-12-25ReiteratedBTIGBuy$45 → $50
Mar-28-25ReiteratedGuggenheim$37 → $30
Feb-28-25ReiteratedRobert W. Baird$36 → $37
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue340344332
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A787160
Gross Profit262273272
Selling, General and Administrative Excl. Other236229200
Research and Development545252
Other Operating Expense63511
Operating Income-33-439
Interest Expense001
Unusual Expense
———
Non-Operating Income (Expense)-15-13-13
Net Income Before Taxes-17-3022
Income Taxes-5-53
Consolidated Net Income-13-2418
Net Income From Continuing Operations-13-2418
Net Income-13-2418
EPS (Recurring)-0.43-0.830.66
EPS (Basic, Before Extraordinaries)-0.43-0.830.66
EPS (Diluted)-0.44-0.830.62
EBITDA-11138
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.863.28—
Gross Margin77.0679.3681.93
Operating Margin-9.71-12.502.71
Net Margin-3.82-6.985.42
Shares Outstanding302928
Market Capitalization6341,128—
Operating Lease Expense
———
Insider Trading Volume
$23.06$20.40$17.74$15.08$12.42● Close Price0.00M0.90M1.79M2.69M3.59MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
MAETZOLD DEREK JPres. & Chief Exec. OfficerJun 15 '26Option Exercise2.391,1002,63091,881Jun 17 12:00 AM
MAETZOLD DEREK JPres. & Chief Exec. OfficerJun 15 '26Sale20.663,33868,96312,646Jun 17 12:00 AM
Cole G BradleyDirectorMay 22 '26Option Exercise0.0027,334032,976May 27 12:00 AM
BRADBURY DANIELDirectorMay 22 '26Option Exercise0.0027,334022,340May 27 12:00 AM
Harrison MilesDirectorMay 22 '26Option Exercise0.0027,334035,631May 27 12:00 AM
Olson TiffanyDirectorMay 22 '26Option Exercise0.0027,334039,573May 27 12:00 AM
Goldberg EllenDirectorMay 22 '26Option Exercise0.0027,334040,921May 27 12:00 AM
Caple KimDirectorMay 22 '26Option Exercise0.0027,334036,121May 27 12:00 AM
Cotton RodneyDirectorMay 22 '26Option Exercise0.0027,334032,998May 27 12:00 AM
Juvenal Tobin WChief Commercial OfficerMay 21 '26Option Exercise3.3822,42075,78098,035May 26 12:00 AM
MAETZOLD DEREK JPres. & Chief Exec. OfficerMay 21 '26Sale20.202,54751,4391,946May 22 12:00 AM
MAETZOLD DEREK JPres. & Chief Exec. OfficerMay 21 '26Option Exercise2.398402,00821,899May 22 12:00 AM
MAETZOLD DEREK JPres. & Chief Exec. OfficerMay 20 '26Sale20.0079115,8222,158May 22 12:00 AM
MAETZOLD DEREK JPres. & Chief Exec. OfficerMay 20 '26Option Exercise2.3926062221,609May 22 12:00 AM
MAETZOLD DEREK JPres. & Chief Exec. OfficerMay 07 '26Sale22.159,002199,4282,224May 11 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR